Immuneering Corp - Ordinary Shares Class A Live Stock Price Today, Share Analysis and Chart

Name: Immuneering Corp - Ordinary Shares Class A: Is Infosys Ltd. worth buying?
Item: Immuneering Corp - Ordinary Shares Class A
Rating: 2.12825
Author: Trendlyne DVM scores

about

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

8.32 0.18 (2.21%)

New 52W High in past week

700.5K

XNAS Volume

XNAS 11 Sep, 2025 1:58 PM (EDT)

Not Eligible

Expensive Valuation

2.0 / 100

Technically Bullish

83.1 / 100

No estimates available

Immuneering Corp Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Immuneering Corp - Ordinary Shares Class A Live Stock Price Today, Share Analysis and Chart

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug dev...

New 52W High in past week

SWOT Analysis

Immuneering Corp Ordinary Live Price Chart